41. Jahrestagung und 19. Fortbildungskurs der österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH)

Abstracts (HTML) List of Authors

Papay, P.

Maintenance therapy with azathioprine (AZA)/6-mercaptopurine (6-MP) in Crohn's disease (CD) reduces the risk of re-operation particularly in smokers
Discrepant results between routine screening for latent tuberculosis (TB) and Quantiferon® in patients with inflammatory bowel diseases (IBD)

Paulinska, P.

Discrepant results between routine screening for latent tuberculosis (TB) and Quantiferon® in patients with inflammatory bowel diseases (IBD)

Peck-Radosavljevic, M.

5 Years Experience of the Vienna Hepatic Hemodynamic Laboratory
Octreotide treatment of patients with hepatocellular carcinoma – A retrospective single centre controlled study
IP-10 predicts HCV clearance, relapse or nonresponse in HIV-HCV-coinfection
Value of von Willebrand factor antigen as a predictor of response to antiviral therapy in patients suffering from chronic hepatitis C

Pesa, J. A.

Maintenance therapy with Infliximab reduces hospitalization and surgery in Crohn's disease

Piringer, P.

Langzeitüberleben von intensivpflichtigen Patienten mit Leberzirrhose

Pramhas, S.

Value of von Willebrand factor antigen as a predictor of response to antiviral therapy in patients suffering from chronic hepatitis C

Prayer, D.

Laminäre Cortexnekrose: Eine irreversible Komplikation mitochondrialer Dysfunktion Bei hepatischer Enzephalopathie und Hyperammoniämie

Puchhammer-Stöckl, E.

Verteilung von Hepatitis B Virus-Genotypen und Resistenzmutationen in Patienten mit chronischer Hepatitis B Virusinfektion in Wien

Püspök, A.

Malt-Lymphom und Enteroskopie: Dünndarmbeteiligung bei bekanntem Magenbefall?
Temoporfin verbessert die tumorizide Eindringtiefe der photodynamischen Therapie beim Gallengangskarzinom
Hospitalization, frequency of interventions and quality of life after endoscopic, surgical or conservative treatment in patients with chronic pancreatitis

Putz-Bankuti, C.

Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis